-
1
-
-
0031031440
-
Primary pulmonary hypertension
-
Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997; 336: 111-117.
-
(1997)
N. Engl. J. Med.
, vol.336
, pp. 111-117
-
-
Rubin, L.J.1
-
2
-
-
0024422399
-
Primary pulmonary hypertension. Vascular structure, morphometry and responsiveness to vasodilators agents
-
Palevsky HI, Schloo BL, Pietra GG, et al. Primary pulmonary hypertension. Vascular structure, morphometry and responsiveness to vasodilators agents. Circulation 1989; 80: 1207-1221.
-
(1989)
Circulation
, vol.80
, pp. 1207-1221
-
-
Palevsky, H.I.1
Schloo, B.L.2
Pietra, G.G.3
-
3
-
-
0031869664
-
Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension
-
Sitbon O, Humbert M, Jagot JL, et al. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. Eur Respir J 1998; 12: 265-270.
-
(1998)
Eur. Respir. J.
, vol.12
, pp. 265-270
-
-
Sitbon, O.1
Humbert, M.2
Jagot, J.L.3
-
4
-
-
0037111455
-
Therapy of pulmonary hypertension: The evolution from vasodilators to antiproliferative agents
-
Rubin LJ. Therapy of pulmonary hypertension: the evolution from vasodilators to antiproliferative agents. Am J Respir Crit Care Med 2002; 166: 1309-1310.
-
(2002)
Am. J. Respir. Crit. Care Med.
, vol.166
, pp. 1309-1310
-
-
Rubin, L.J.1
-
5
-
-
0030031888
-
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
-
Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334: 296-302.
-
(1996)
N. Engl. J. Med.
, vol.334
, pp. 296-302
-
-
Barst, R.J.1
Rubin, L.J.2
Long, W.A.3
-
6
-
-
0037149718
-
Bosentan therapy for pulmonary arterial hypertension
-
Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346: 896-903.
-
(2002)
N. Engl. J. Med.
, vol.346
, pp. 896-903
-
-
Rubin, L.J.1
Badesch, D.B.2
Barst, R.J.3
-
7
-
-
0037151645
-
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survival
-
Sitbon O, Humbert M, Nunes H, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002; 40: 780-788.
-
(2002)
J. Am. Coll. Cardiol.
, vol.40
, pp. 780-788
-
-
Sitbon, O.1
Humbert, M.2
Nunes, H.3
-
8
-
-
0037126044
-
Survival in primary pulmonary hypertension: The impact of epoprostenol therapy
-
McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 2002; 106: 1477-1482.
-
(2002)
Circulation
, vol.106
, pp. 1477-1482
-
-
McLaughlin, V.V.1
Shillington, A.2
Rich, S.3
-
9
-
-
0036800014
-
The new clinical trials on pharmacological treatment in pulmonary arterial hypertension
-
Galiè N, Manes A, Branzi A. The new clinical trials on pharmacological treatment in pulmonary arterial hypertension. Eur Respir J 2002; 20: 1037-1049.
-
(2002)
Eur. Respir. J.
, vol.20
, pp. 1037-1049
-
-
Galiè, N.1
Manes, A.2
Branzi, A.3
-
10
-
-
0037086133
-
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A double-blind randomized controlled trial
-
Simonneau G, Barst RJ, Galiè N, et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind randomized controlled trial. Am J Respir Crit Care Med 2002; 165: 800-804.
-
(2002)
Am. J. Respir. Crit. Care Med.
, vol.165
, pp. 800-804
-
-
Simonneau, G.1
Barst, R.J.2
Galiè, N.3
-
11
-
-
0036569119
-
Effects of beraprost sodium, an oral prostaeyclin analogue, in patients with pulmonary arterial hypertension: A randomized, double-blind placebo-controlled trial
-
Galiè N, Humbert M, Vachiéry JL, et al Effects of beraprost sodium, an oral prostaeyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind placebo-controlled trial. J Am Coll Cardiol 2002; 39: 1496-1502.
-
(2002)
J. Am. Coll. Cardiol.
, vol.39
, pp. 1496-1502
-
-
Galiè, N.1
Humbert, M.2
Vachiéry, J.L.3
-
12
-
-
0036682273
-
Inhaled iloprost in severe pulmonary hypertension
-
Olschewski H, Simonneau G, Galiè N, et al. Inhaled iloprost in severe pulmonary hypertension. N Engl J Med 2002; 347: 322-327.
-
(2002)
N. Engl. J. Med.
, vol.347
, pp. 322-327
-
-
Olschewski, H.1
Simonneau, G.2
Galiè, N.3
-
13
-
-
0036283401
-
Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension
-
Barst RJ, Rich SA, Horn EM, McLaughlin VV, McFarlin J. Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension. Chest 2002; 121: 1860-1868.
-
(2002)
Chest
, vol.121
, pp. 1860-1868
-
-
Barst, R.J.1
Rich, S.A.2
Horn, E.M.3
McLaughlin, V.V.4
McFarlin, J.5
-
15
-
-
0037484589
-
Effect of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: A one year follow-up study
-
(in press)
-
Sitbon O, Badesch DB, Cjannick RN, et al. Effect of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a one year follow-up study. Chest 2003; (in press).
-
(2003)
Chest
-
-
Sitbon, O.1
Badesch, D.B.2
Cjannick, R.N.3
-
16
-
-
0041742185
-
Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids
-
Hoeper MM, Taha N, Bekjarova A, Gatzke R, Spickerkoetter E. Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids. Eur Respir J 2003; 22: 330-334.
-
(2003)
Eur. Respir. J.
, vol.22
, pp. 330-334
-
-
Hoeper, M.M.1
Taha, N.2
Bekjarova, A.3
Gatzke, R.4
Spickerkoetter, E.5
-
17
-
-
0037868048
-
Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension
-
(in press)
-
Ghofrani A, Rose F, Schermuly RT, et al. Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension. J Am Coll Cardiol 2003; (in press).
-
(2003)
J. Am. Coll. Cardiol.
-
-
Ghofrani, A.1
Rose, F.2
Schermuly, R.T.3
-
18
-
-
0032145492
-
Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension: A therapeutic alternative for patients nonresponsive to vasodilator treatment
-
Sandoval J, Gaspar J, Pulido T, et al. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension: a therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol 1998; 32: 297-304.
-
(1998)
J. Am. Coll. Cardiol.
, vol.32
, pp. 297-304
-
-
Sandoval, J.1
Gaspar, J.2
Pulido, T.3
-
20
-
-
0034122586
-
Sildenafil can increase the response to inhaled nitric oxide
-
Bigatello LM, Hess D, Dennehy KC, Medoff BD, Hurford WE. Sildenafil can increase the response to inhaled nitric oxide. Anesthesiology 2000; 92: 1827-1829.
-
(2000)
Anesthesiology
, vol.92
, pp. 1827-1829
-
-
Bigatello, L.M.1
Hess, D.2
Dennehy, K.C.3
Medoff, B.D.4
Hurford, W.E.5
-
21
-
-
0037006966
-
Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension
-
Ghofrani HA, Wiedemann R, Rose F, et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 2002; 136: 515-522.
-
(2002)
Ann. Intern. Med.
, vol.136
, pp. 515-522
-
-
Ghofrani, H.A.1
Wiedemann, R.2
Rose, F.3
-
22
-
-
0036852964
-
Amplification of the pulmonary vasodilatory response to inhaled iloprost by subtreshold phosphodiesterases types 3 and 4 inhibition in severe pulmonary hypertension
-
Ghofrani HA, Rose F, Schermuly RT, et al. Amplification of the pulmonary vasodilatory response to inhaled iloprost by subtreshold phosphodiesterases types 3 and 4 inhibition in severe pulmonary hypertension. Crit Care Med 2002; 30: 2489-2492.
-
(2002)
Crit. Care Med.
, vol.30
, pp. 2489-2492
-
-
Ghofrani, H.A.1
Rose, F.2
Schermuly, R.T.3
-
23
-
-
0041782976
-
Safety and efficacy of bosentan in combination with epoprostenol in patients with severe pulmonary arterial hypertension
-
(abstract)
-
Humbert M, Barst RJ, Robbins I, et al Safety and efficacy of bosentan in combination with epoprostenol in patients with severe pulmonary arterial hypertension (abstract). Am J Respir Crit Care Med 2003; 167: A441.
-
(2003)
Am. J. Respir. Crit. Care Med.
, vol.167
-
-
Humbert, M.1
Barst, R.J.2
Robbins, I.3
|